SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000863894-24-000006
Filing Date
2024-04-01
Accepted
2024-04-01 15:30:24
Documents
99
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-K/A veru-20230930x10ka.htm   iXBRL 10-K/A 4674481
2 EX-23.1 veru-20230930xex23_1.htm EX-23.1 5586
3 EX-31.1 veru-20230930xex31_1.htm EX-31.1 15579
4 EX-31.2 veru-20230930xex31_2.htm EX-31.2 15487
5 EX-32.1 veru-20230930xex32_1.htm EX-32.1 11599
  Complete submission text file 0000863894-24-000006.txt   18846430

Data Files

Seq Description Document Type Size
6 EX-101.SCH veru-20230930.xsd EX-101.SCH 80009
7 EX-101.CAL veru-20230930_cal.xml EX-101.CAL 95918
8 EX-101.DEF veru-20230930_def.xml EX-101.DEF 322846
9 EX-101.LAB veru-20230930_lab.xml EX-101.LAB 571522
10 EX-101.PRE veru-20230930_pre.xml EX-101.PRE 550272
103 EXTRACTED XBRL INSTANCE DOCUMENT veru-20230930x10ka_htm.xml XML 4731855
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-13602 | Film No.: 24808705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)